These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 9197878)
21. The relationship between breast density and bone mineral density in never users of postmenopausal hormone therapy. Seckin B; Pekcan MK; Inal HA; Gulerman C Aging Clin Exp Res; 2017 Jun; 29(3):537-541. PubMed ID: 27294615 [TBL] [Abstract][Full Text] [Related]
22. Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma. Reverter JL; Holgado S; Alonso N; Salinas I; Granada ML; SanmartĂ A Endocr Relat Cancer; 2005 Dec; 12(4):973-81. PubMed ID: 16322336 [TBL] [Abstract][Full Text] [Related]
24. Thyroid hormone use and bone mineral density in elderly women. Effects of estrogen. Schneider DL; Barrett-Connor EL; Morton DJ JAMA; 1994 Apr; 271(16):1245-9. PubMed ID: 7848399 [TBL] [Abstract][Full Text] [Related]
25. [Effects of estrogen therapy on bone mass in postmenopausal women with osteopenia]. Insua A; Negri A; Zanchetta JR Medicina (B Aires); 1995; 55(5 Pt 1):408-14. PubMed ID: 8728770 [TBL] [Abstract][Full Text] [Related]
26. The effects of short-term hormone replacement therapy on long-term bone mineral density. Middleton ET; Steel SA Climacteric; 2007 Jun; 10(3):257-63. PubMed ID: 17487653 [TBL] [Abstract][Full Text] [Related]
27. Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post-menopausal women who have previously received long-term oral oestrogens. Savvas M; Studd JW; Norman S; Leather AT; Garnett TJ; Fogelman I Br J Obstet Gynaecol; 1992 Sep; 99(9):757-60. PubMed ID: 1420016 [TBL] [Abstract][Full Text] [Related]
28. Anabolic effect of long-term estrogen replacement on bone collagen in elderly postmenopausal women with osteoporosis. Khastgir G; Studd J; Holland N; Alaghband-Zadeh J; Sims TJ; Bailey AJ Osteoporos Int; 2001; 12(6):465-70. PubMed ID: 11446562 [TBL] [Abstract][Full Text] [Related]
29. Disuse osteopenia following leg fracture in postmenopausal women: Implications for HIP fracture risk and fracture liaison services. Hopkins SJ; Toms AD; Brown M; Appleboam A; Knapp KM Radiography (Lond); 2018 May; 24(2):151-158. PubMed ID: 29605113 [TBL] [Abstract][Full Text] [Related]
30. The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone. Han KO; Choi JT; Choi HA; Moon IG; Yim CH; Park WK; Yoon HK; Han IK Clin Endocrinol (Oxf); 2005 Mar; 62(3):349-53. PubMed ID: 15730418 [TBL] [Abstract][Full Text] [Related]
31. The association between lipid profile and bone density in postmenopausal women. Begic Z; Balic D; Rizvanovic M Med Arch; 2012; 66(6):378-81. PubMed ID: 23409515 [TBL] [Abstract][Full Text] [Related]
32. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lindsay R; Nieves J; Formica C; Henneman E; Woelfert L; Shen V; Dempster D; Cosman F Lancet; 1997 Aug; 350(9077):550-5. PubMed ID: 9284777 [TBL] [Abstract][Full Text] [Related]
33. The effect of 1-year transdermal estrogen replacement therapy on bone mineral density and biochemical markers of bone turnover in osteopenic postmenopausal systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. Bhattoa HP; Bettembuk P; Balogh A; Szegedi G; Kiss E Osteoporos Int; 2004 May; 15(5):396-404. PubMed ID: 14676992 [TBL] [Abstract][Full Text] [Related]
34. Calcium supplements increase bone mineral density in women with low serum calcium levels during long-term estrogen therapy. Mizunuma H; Okano H; Soda M; Tokizawa S; Kagami I; Miyamoto S; Honjo S; Ibuki Y Endocr J; 1996 Aug; 43(4):411-5. PubMed ID: 8930529 [TBL] [Abstract][Full Text] [Related]
35. A comparison of 25 mg and 50 mg oestradiol implants in the control of climacteric symptoms following hysterectomy and bilateral salpingo-oophorectomy. Panay N; Versi E; Savvas M BJOG; 2000 Aug; 107(8):1012-6. PubMed ID: 10955434 [TBL] [Abstract][Full Text] [Related]
36. Effects on bone of surgical menopause and estrogen therapy with or without progesterone replacement in cynomolgus monkeys. Jayo MJ; Weaver DS; Adams MR; Rankin SE Am J Obstet Gynecol; 1990 Aug; 163(2):614-8. PubMed ID: 2386153 [TBL] [Abstract][Full Text] [Related]
37. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group. Hosking D; Chilvers CE; Christiansen C; Ravn P; Wasnich R; Ross P; McClung M; Balske A; Thompson D; Daley M; Yates AJ N Engl J Med; 1998 Feb; 338(8):485-92. PubMed ID: 9443925 [TBL] [Abstract][Full Text] [Related]
38. Effects of transdermal estradiol delivered by a matrix patch on bone density in hysterectomized, postmenopausal women: a 2-year placebo-controlled trial. Arrenbrecht S; Boermans AJ Osteoporos Int; 2002; 13(2):176-83. PubMed ID: 11908492 [TBL] [Abstract][Full Text] [Related]
39. Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo Study. Schneider DL; Barrett-Connor EL; Morton DJ JAMA; 1997 Feb; 277(7):543-7. PubMed ID: 9032160 [TBL] [Abstract][Full Text] [Related]
40. Steroid hormone levels in postmenopausal hysterectomised women with and without ovarian conservation: the continuous endocrine function of the ovaries. Nunes E; Gallardo E; Morgado-Nunes S; Fonseca-Moutinho J J Obstet Gynaecol; 2023 Dec; 43(1):2141618. PubMed ID: 36331514 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]